Staar Surgical Co (STAA) Stock Price
STAAStock
$21.27−12.32%52W
Market Cap$1.07B
P/E—
PEG Ratio0.76
Div yield—
Beta1.23
STAA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-22.84%
Price vs S&P 500 (4W)6.00%
PEG Ratio0.76
VGM Score47.79
STAA Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.23 | $0.25 | +9.71%(+$0.02) | |
| Q1 2026 | $0.08 | $0.29 | +266.75%(+$0.21) | |
| Q4 2025 | $0.17 | $0.01 | -95.19%(-$0.16) | |
| Q3 2025 | $0.28 | $0.47 | +68.34%(+$0.19) | |
| Q2 2025 | -$0.56 | -$0.13 | +77.02%(+$0.43) |
STAA Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.65
3.65
3.56
3.56
Industry Peers — Ophthalmic Goods(8)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
STAAStaar Surgical Co | D | B | C | — | 1.1% | 7.9% | — | $21.27 |
| ALCAlcon Inc. Ordinary Shares | C | C | C | 34.1x | 2.9% | 8.8% | 0.3% | $66.18 |
| COOThe Cooper Companies, Inc. Common Stock | B | B | C | 29.4x | 6.9% | 11.0% | 0.0% | $57.94 |
| BLCOBausch + Lomb Corporation | B | D | B | — | -2.7% | 8.4% | — | $16.49 |
| WRBYWarby Parker Inc. | D | B | C | 1711.4x | 2.1% | 17.2% | — | $23.34 |
| EYENational Vision Holdings, Inc. Common Stock | A | D | C | 46.6x | 5.7% | 3.0% | — | $17.43 |
| RXSTRxSight, Inc. Common Stock | B | C | D | — | -17.4% | 55.7% | — | $4.51 |
| LUCYInnovative Eyewear, Inc. Common Stock | B | A | D | — | -88.9% | 113.5% | — | $0.79 |
| LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27 | — | — | F | — | — | — | — | $0.03 |
About Staar Surgical Co
STAAR Surgical Co manufactures Implantable Collamer Lenses (ICL) and delivery systems for refractive eye surgery. The company derives nearly all revenue from ICL sales, which are used to correct myopia and other refractive errors. A substantial portion of revenues comes from international markets.